Abott recalled 4,800 Dragonfly OpStar imaging catheters May 26 due to the marker band becoming loose and, in two instances, separating from the device.
The infant formula shortage will likely last until late July, FDA Commissioner Robert Califf, MD, said during a Senate Health Committee meeting, The Hill reported May 26.
Coral Gables, Fla.-based Baptist Health South Florida and Medline entered a partnership May 24 to “identify new strategies for enhancing data-driven operational and clinical efficiencies.”
The FDA and Phillips Respironics provided updates on the mechanical ventilators that were recalled in June 2021 resulting in more than 21,000 medical device reports, 124 of which were tied to deaths.
The closure of a Teva Pharmaceuticals manufacturing plant in Irvine, Calif., could affect the availability of 24 generic sterile injectable drugs, including five essential medicines, according to the first analysis from the End Drug Shortages Alliance.
Robert Ford, CEO of Abbott, apologized for the role the company played in a nationwide shortage of baby formula in a May 21 op-ed for The Washington Post.